Professor S. Moira Brown awarded an OBE in the
New Year Honours List 2007 for services to Healthcare as Director
and Chief Scientist of Crusade Laboratories Ltd.
Significant Achievements
Awarded Orphan Medicinal Product designation for
“herpes simplex virus lacking infected cell protein 34.5”
(HSV1716) for the treatment of glioma, 9th July 2003
Received approval from Department
of Health, Gene Therapy Advisory Committee (GTAC) to commence
“A Randomised Efficacy Trial of Herpes Simplex Virus HSV1716
in Recurrent Glioblastoma Multiforme”, 27th July 2004
Received a “Notice of Acceptance” from
the Medicines and Healthcare products Regulatory Agency (MHRA)
for a request to carry out “A Randomised Efficacy Trial
of Herpes Simplex Virus HSV1716 in Recurrent Glioblastoma Multiforme”,
9th September 2004.
Ongoing Collaborations
University of Birmingham, UK
NHS Greater Glasgow, South Glasgow University
Hospitals Division UK
University of Cologne, Germany
Max Planck Institute for Neurological Research,
Germany
Memorial Sloan-Kettering Cancer Centre, New York,
USA
